Generic to Zegerid and Zegerid OTC Launched
July 18, 2016 – Dr. Reddy’s launched A-rated generics to Zegerid® capsules. Zegerid, manufactured by Salix Pharmaceuticals, is approved for the short-term treatment of stomach and duodenal ulcers, erosive esophagitis and heartburn associated with gastroesophageal reflux disease (GERD). Dr. Reddy, the manufacturer of the generic omeprazole and sodium bicarbonate (20mg/1100mg and 40mg/1100mg) capsules are available in a 30 count bottle size.
Perrigo also announced the launch of its store brand equivalent to Zegerid OTC® (omeprazole/sodium bicarbonate) 20mg/1100mg capsules, manufactured by Bayer. Zegerid OTC is approved for the treatment of frequent heartburn. The generic version will be packaged and marketed as a store brand or retailer owned brand label as a “value-priced” alternative to Zegerid OTC.
Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval. Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval. Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.
*This is provided for information only. The reference to any medication above does not mean the medication is covered by your plan.